Education
About Us
Working with TipRanks
Follow Us
Najat Khan Insider Profile
11 Followers
Najat Khan, Chief R&D Commercial Officer, Director at Recursion Pharmaceuticals, holds 668.20K shares in Recursion Pharmaceuticals (Ticker: RXRX). Most recently, Najat Khan Sold 40,388 shares of Recursion Pharmaceuticals on Aug 19, 2025 for an estimated value of $223.40K.
Najat Khan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief R&D Commercial Officer, Director
Roles that Najat Khan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Najat Khan
Najat Khan's Trading History
List of latest transactions for each holding click on a transaction to see Najat Khan's performance on stock
You May Also Like
Najat Khan insider profile FAQ
What is the percentage of profitable transactions made by Najat Khan?
The percentage of profitable transactions made by Najat Khan is ―.
What is the average return per transaction made by Najat Khan?
The average return per transaction made by Najat Khan is ―.
What stocks does Najat Khan hold?
Najat Khan holds: RXRX stocks.
What was Najat Khan’s latest transaction?
Najat Khan latest transaction was an Informative Sell of $223.40K.
What was Najat Khan's most profitable transaction?
Najat Khan’s most profitable transaction was an Informative Sell of RXRX stock on August 19, 2025. The return on the trade was 3.50%.
What is Najat Khan's role in Recursion Pharmaceuticals?
Najat Khan's role in Recursion Pharmaceuticals is Chief R&D Commercial Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.